home / stock / seovf / seovf news

SEOVF News and Press, Sernova Corp From 09/07/22

Stock Information
Company Name: Sernova Corp
Stock Symbol: SEOVF
Market: OTC
Website: sernova.com
Menu
SEOVF SEOVF Quote SEOVF Short SEOVF News SEOVF Articles SEOVF Message Board
Get SEOVF Alerts

News, Short Squeeze, Breakout and More Instantly...
SEOVF - Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors

- Successful biopharma entrepreneur with 25 years of experience growing leading healthcare firms - LONDON, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeut...
SEOVF - Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share

LONDON, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/ XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that it has completed the second and final tranche of its previously announced private ...

SEOVF - Sernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.

LONDON, Ontario, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that Dr. Philip Toleikis, President & CEO of Sernova Corp, will participate in a fire...

SEOVF - Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June

LONDON, Ontario, June 15, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that Dr. Philip Toleikis, President & CEO of Sernova Corp, will be participating in t...
SEOVF - Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System(TM) at American Diabetes Association 82nd Scientific Sessions 2022

Researchers from the Dr. Piotr Witkowski Laboratory at the University of Chicago presented updated data on six patients with type 1 diabetes and hypoglycemia unawareness The first three patients have been insulin independent for over 2 years, 6 months, and 3 months, respective...

SEOVF - SERNOVA SHARES to Commence Trading on TSX On June 2, 2022

(TheNewswire) London, Ontario – TheNewswire - June 1 , 2022 – Sernova Corp. (TSXV:SVA ) ; ( OTC:SEOVF ) ; ( FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeut...

SEOVF - Sernova Receives Conditional Approval to Up-list to the Toronto Stock Exchange

(TheNewswire) London, Ontario – TheNewswire - May 24 , 2022 – Sernova Corp. (TSXV:SVA; ) ( OTC:SEOVF ) ; ( FSE: PSH); ( XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell t...
SEOVF - Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a 'Functional Cure' for Diabetes

Partnership Leverages Sernova’s Proprietary Cell Pouch System™ with Evotec’s iPSC-Based Insulin-Producing Beta Cells Partners to Develop and Commercialize an Off-The-Shelf Cell Replacement Therapy for Treatment of Patients with Insulin-Dependent Diabetes ...

SEOVF - Evotec teams up with Sernova to develop diabetes therapy, commits Euro20M equity investment

Germany-based Evotec (NASDAQ:EVO) (OTCPK:EVOTF) and Canada's Sernova (OTCQB:SEOVF) are collaborating to develop a therapy for diabetes. The companies plan to develop an implantable iPSC-based beta cell replacement therapy to treat insulin-dependent diabetes, including type 1 and 2. Under...

SEOVF - Sernova Announces Abstract on Phase 1/2 Trial with Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 82nd Scientific Sessions 2022

(TheNewswire) LONDON, ONTARIO – TheNewswire - May 9, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage cell therapy therapeutics company focused on developing a potential ‘functional cure’ for type 1 diabetes (T1D...
Previous 10 Next 10